Breaking News
FONT-SIZE Plus   Neg
Share SHARE

Lennox Int'l Issues FY13 Guidance, Backs FY12 Outlook

RELATED NEWS
Trade LII now with 

Lennox International Inc. (LII: Quote), maker of heating and cooling equipments, Wednesday detailed a guidance for the full year 2013, the mid-point of which is expected to beat current Street estimates. The company also confirmed its guidance for the full year 2012.

Richardson, Texas-based Lennox expects earnings from continuing operations of $3.15 to $3.55 per share for the full year 2013. Analysts polled by Thomson Reuters currently expect earnings of $3.32 per share. Analysts' estimates typically exclude one-time items.

Lennox targets to grow 2013 revenues in a range of 2 to 6 percent, with a neutral impact from foreign exchange. The company plans capital expenditures of about $60 million in 2013.

For the full year 2012, Lennox continues to expect earnings from continuing operations of $2.55 to $2.75 per share, adjusted earnings of $2.60 to $2.80 per share and revenue growth of 4 to 6 percent. Analysts currently expect earnings of $2.74 per share on revenues of $2.95 billion.

Lennox makes climate control products for the heating, ventilation, air conditioning, and refrigeration markets in North America and internationally.

LII is currently trading at $51.12, up $0.13 or 0.25%, on a volume of 0.23 million shares.

Register
To receive FREE breaking news email alerts for Lennox International Inc and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
Swiss drug maker Roche Holding said a late-stage trial of its breast cancer drug Kadcyla did not provide superior results compared with an existing therapy. FCA US, until recently known as Chrysler, said Friday it is recalling 257,000 Dodge Ram pickups. The auto maker says the rear axle pinion nut on certain model year 2005 Dodge Ram 1500 trucks may loosen due to an undersized spline on the pinion gear. If the pinion nut loosens, the rear axle may... This medical device company has a very impressive track record of growing business over the past decade. increasing sales from $490.2 million in 2004 to $1.72 billion this year. The Silicone Hydrogel daily disposable lens portfolio constitutes a major avenue for growth.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.